3.2. Intranasal Vaccination with CC-OMV-M2e Elicits anti-M2e IgG and IgA Titers Post-Infection and Protects Balb/C Mice from Lethal Influenza A/PR8 Challenge. This evidence concerns the gene CD79A and infection.